Bovine collagen usually provides type I/III
The science is promising enough to study closely, but practical decisions should wait for stronger evidence, regulatory decisions, and individualized medical guidance
CU Anschutz Clinical Trial Shows Fewer Heavy Drinking Days PR Newswire AURORA, Colo., July 29, 2026 A study from the University of Colorado Anschutz found that the popular diabetes and weight loss drug reduced heavy drinking and alcohol-related harm in adults with Alcohol Use Disorder AURORA, Colo., July 29, 2026 /PRNewswire/ -- A clinical trial led by researchers at CU Anschutz has found that oral semaglutide, a medication widely used for diabetes and weight loss, reduces heavy drinking in adults with Alcohol Use Disorder (AUD)
Conclusion Tirzepatide shots offer a promising solution for individuals struggling with weight loss
15 mg per day is the recommended daily allowance